RudaCure Inc. attends the Global Bio Expo BIO USA 2024
RudaCure Inc. (hereinafter "RudaCure"), une entreprise spécialisée dans le développement de traitements pour les maladies oculaires et la douleur chronique, attended the 'BIO International Convention 2024' (hereinafter "BIO USA") held in San Diego, USA from June 3 to June 6. BIO USA is the world's largest biotechnologienologie industrie expo, offering a complet view of the latest trends and innovant technologies in the global bio industrie.
At this expo, RudaCure showcased its latest R&D achievements and technological capabilities while exploring opportunities to build global partenariats and collaborations. En particulier, RudaCure's key products—traitement de la sécheresse oculaire (RCI001) and traitement de l'ulcère cornéen (RCI001U)—drew significatif attention from attendees.
Throughout the event, RudaCure conducted business meetings with a variety of global pharmaceutique and biotechnologie companies, engaging in discussions on transfert de technologie and joint R&D. Through these interactions, RudaCure vise à strengthen its position in the marché mondial and enhance its international compétitivité.
RudaCure plans to grow into a global bioentreprise pharmaceutique that contributes to improving human health and quality of life through continuous R&D and innovation. This participation in BIO USA devrait further solidify RudaCure's standing in the global bio market and mark an important turning point for de l'entreprise future growth.